Elite Pharmaceuticals, Inc. ELTP
0.32 USD 0.00 (+0.00%)
Regular-session close
0.315 Day range 0.336
0.21 52-week range 0.55
- YTD
- -34.69%
- 1 year
- -40.74%
ELTP revenue history
Revenue is income from the company’s ordinary business activities.
1,413,119 USD
FY 2008 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2008 | 2008-03-31 | 1,413,119 | 269,278 | 23.54% |
| FY 2007 | 2007-03-31 | 1,143,841 | 593,144 | 107.71% |
| FY 2006 | 2006-03-31 | 550,697 | 249,217 | 82.66% |
| FY 2005 | 2005-03-31 | 301,480 | 43,230 | 16.74% |
| FY 2004 | 2004-03-31 | 258,250 | -372,060 | -59.03% |
| FY 2003 | 2003-03-31 | 630,310 | -567,197 | -47.36% |
| FY 2002 | 2002-03-31 | 1,197,507 | 1,102,261 | 1157.28% |
| FY 2001 | 2001-03-31 | 95,246 | 84,931 | 823.37% |
| FY 2000 | 2000-03-31 | 10,315 | -140,097 | -93.14% |
| FY 1999 | 1999-03-31 | 150,412 | 98,454 | 189.49% |
| FY 1998 | 1998-03-31 | 51,958 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
